Price Alert

Enlivex Therapeutics Ltd. (ENLV)

NASDAQ: ENLV · Real-Time Price · USD

1.82

0.04 (2.25%)

At close: Aug 15, 2025, 3:59 PM

1.91

4.95%

After-hours: Aug 15, 2025, 07:55 PM EDT

Enlivex Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	2.05M	3.3M	2.77M	3.75M	2.03M	926K	1.97M	3.46M	13.14M	47.82M	38.55M	20.15M	67.67M	11.2M	22.15M	12.61M	4.09M
Short-Term Investments	18.5M	20.2M	21.73M	22.2M	21.52M	26.51M	28.53M	25.44M	22.84M	299K	n/a	42.33M	10.34M	72.93M	65.48M	77.99M	87.58M
Long-Term Investments	n/a	531K	n/a	1.21M	319K	308K	284K	7.45M	7.55M	307K	283K	286K	312K	3K	307K	88K	86K
Other Long-Term Assets	319K	10K	915K	92K	110K	179K	512K	485K	104K	105K	139K	118K	136K	482K	6K	6K	5K
Receivables	1.23M	1.3M	1.29M	1.15M	3.81M	229K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.09M	n/a	n/a	885K
Inventory	n/a	n/a	113K	113K	n/a	-229K	-1.23M	-1.77M	-1.49M	1.18M	19.1M	n/a	n/a	n/a	n/a	n/a	-885K
Other Current Assets	119K	198K	228K	228K	4.04M	5.34M	n/a	n/a	n/a	n/a	113K	113K	113K	1.2M	874K	883K	340K
Total Current Assets	22.65M	25.99M	27.11M	28.57M	28.38M	33.76M	31.84M	30.79M	37.58M	52.33M	59.23M	65.05M	79.3M	86.44M	90.28M	92.83M	93.78M
Property-Plant & Equipment	1.07M	1.15M	1.77M	2.03M	2.24M	2.58M	14.3M	14.31M	14.79M	14.9M	12.76M	11.89M	8.87M	8.22M	7.57M	2.27M	2.1M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.39M	1.69M	2.69M	3.33M	2.67M	3.07M	15.1M	22.24M	22.44M	15.31M	13.18M	12.29M	9.32M	8.7M	7.89M	2.36M	2.19M
Total Assets	24.04M	27.69M	29.8M	31.9M	31.05M	36.83M	46.94M	53.03M	60.02M	67.64M	72.41M	77.34M	88.62M	95.15M	98.17M	95.19M	95.96M
Account Payables	533K	811K	92K	303K	643K	827K	794K	1.55M	1.48M	1.95M	1.06M	667K	1.36M	878K	1.06M	558K	347K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	1.41M	1.55M	301K	291K	n/a	1.23M	n/a	n/a	n/a	n/a	113K	113K	113K	n/a	792K	793K	1.15M
Total Current Liabilities	3.14M	3.8M	2.79M	2.84M	3.61M	6.06M	4.34M	4.99M	5.45M	6.61M	4.53M	4.21M	5.74M	4.72M	4.73M	4.58M	4.91M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4.61M	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-4.61M	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	264K	299K	419K	499K	587K	686K	3.82M	3.7M	4M	4.19M	4.61M	4.64M	5.23M	5.39M	5.35M	405K	449K
Total Liabilities	3.41M	4.1M	3.21M	3.34M	4.2M	6.75M	8.16M	8.69M	9.45M	10.8M	9.14M	8.86M	10.97M	10.11M	10.08M	4.98M	5.36M
Total Debt	503K	534K	765K	835K	928K	1.03M	4.52M	4.37M	4.68M	4.85M	5.26M	629K	694K	617K	636K	210K	205K
Common Stock	2.71M	2.69M	2.5M	2.38M	2.16M	2.14M	2.14M	2.14M	2.13M	2.12M	2.12M	2.11M	2.11M	2.11M	2.11M	2.1M	2.1M
Retained Earnings	-130.56M	-127.11M	-121.93M	-119.33M	-116.23M	-112.09M	-103M	-97.03M	-90.24M	-83.03M	-75.84M	-70.1M	-60.19M	-51.97M	-47.23M	-43.8M	-40.7M
Comprehensive Income	1.1M	1.1M	1.1M	1.1M	1.1M	1.1M	1.1M	1.1M	1.1M	1.1M	1.1M	1.1M	1.1M	1.1M	1.1M	244K	-1.81M
Shareholders Equity	20.63M	23.59M	26.59M	28.56M	26.85M	30.08M	38.78M	44.34M	50.57M	56.84M	63.27M	68.49M	77.65M	85.04M	88.08M	90.21M	90.61M
Total Investments	18.5M	20.73M	21.73M	23.41M	21.84M	26.82M	28.53M	25.44M	22.84M	299K	283K	42.33M	10.34M	72.93M	65.48M	77.99M	87.58M